DeepMed Research

BOSTON MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1996-01-01

Employees: 1K

Market Cap: -

Website: http://www.bmc.org

Clinical Trials

Stereotactic Radiosurgery in Treating Patients With Spinal Metastases

Phase 1

Completed

Conditions: Metastatic Cancer

Interventions: Other: questionnaire administration
Procedure: diffusion tensor imaging
Procedure: functional magnetic resonance imaging
Radiation: single-fraction SRS
Radiation: hypo-fractionated SRS

First Posted Date: 2009-03-02

Last Posted Date: 2017-07-19

Lead Sponsor: Boston Medical Center

Target Recruit Count: 18

Registration Number: NCT00853528

Locations: 🇺🇸
Boston University Cancer Research Center, Boston, Massachusetts, United States

Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Not Applicable

Terminated

Conditions: Lung Cancer

Interventions: Procedure: computed tomography
Radiation: fludeoxyglucose F 18
Radiation: hypofractionated radiation therapy
Radiation: stereotactic radiosurgery

First Posted Date: 2009-02-27

Last Posted Date: 2018-05-11

Lead Sponsor: Boston Medical Center

Target Recruit Count: 9

Registration Number: NCT00852644

Locations: 🇺🇸
Boston University Cancer Research Center, Boston, Massachusetts, United States

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Not Applicable

Completed

Conditions: Head and Neck Cancer

Interventions: Radiation: stereotactic radiosurgery

First Posted Date: 2009-02-25

Last Posted Date: 2018-01-17

Lead Sponsor: Boston Medical Center

Target Recruit Count: 12

Registration Number: NCT00851253

Locations: 🇺🇸
Boston University Cancer Research Center, Boston, Massachusetts, United States

Use of Conversation and Acoustic Signals in Measuring Depression Severity

Completed

Conditions: Depression

First Posted Date: 2009-01-29

Last Posted Date: 2013-04-08

Lead Sponsor: Boston Medical Center

Target Recruit Count: 89

Registration Number: NCT00831935

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States
🇺🇸
Boston University Medical Campus, Boston, Massachusetts, United States

Study of Sacral Fractures Using Patient Based and Objective Outcomes

Completed

Conditions: Sacrum Fracture

First Posted Date: 2008-11-26

Last Posted Date: 2019-09-20

Lead Sponsor: Boston Medical Center

Target Recruit Count: 100

Registration Number: NCT00798733

Locations: 🇺🇸
University of Michigan Hospital, Ann Arbor, Michigan, United States
🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇨🇦
QEII Health Science Center-NHI, Halifax, Canada

and more 11 locations

Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Biological: filgrastim
Drug: bortezomib
Drug: melphalan
Procedure: Stem Cell Infusion

First Posted Date: 2008-11-13

Last Posted Date: 2017-02-06

Lead Sponsor: Boston Medical Center

Target Recruit Count: 10

Registration Number: NCT00790647

Locations: 🇺🇸
Boston University Cancer Research Center, Boston, Massachusetts, United States

A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

Not Applicable

Completed

Conditions: Ankle Injuries

Interventions: Device: Antiglide Plate
Device: Lateral Plate

First Posted Date: 2008-07-18

Last Posted Date: 2017-03-29

Lead Sponsor: Boston Medical Center

Target Recruit Count: 249

Registration Number: NCT00718302

Locations: 🇺🇸
Barnes-Jewish Hospital, St. Louis, Missouri, United States
🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
🇨🇦
Dalhousie University, Halifax, Nova Scotia, Canada

and more 7 locations

HD Melphalan and SCT in Patients With IGDD or LCDD

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Biological: filgrastim
Drug: melphalan
Procedure: Stem Cell Infusion

First Posted Date: 2008-05-20

Last Posted Date: 2017-04-28

Lead Sponsor: Boston Medical Center

Target Recruit Count: 5

Registration Number: NCT00681044

Locations: 🇺🇸
Boston University Cancer Research Center, Boston, Massachusetts, United States

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: dexamethasone
Drug: lenalidomide
Drug: melphalan

First Posted Date: 2008-05-16

Last Posted Date: 2017-02-20

Lead Sponsor: Boston Medical Center

Target Recruit Count: 16

Registration Number: NCT00679367

Locations: 🇺🇸
Boston University Cancer Research Center, Boston, Massachusetts, United States

Clinical Outcomes Following Glenoid Neck Fracture as Correlated With Quantitative Assessment of Osseous Injury

Completed

Conditions: Scapula Fracture
Glenoid; Fracture

Interventions: Other: Scapular with glenoid neck fractures

First Posted Date: 2008-03-27

Last Posted Date: 2020-01-02

Lead Sponsor: Boston Medical Center

Target Recruit Count: 98

Registration Number: NCT00644813

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
Orthopaedic Associates of Michigan, Grand Rapids, Michigan, United States
🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy